Latest News
Keep up-to-date with BMS Canada
-
MONTREAL, QUEBEC – October 26, 2010
Newest Treatment for Schizophrenia & Related Psychotic Disorders now Available to all Quebecers
ABILIFY™ reimbursed as a full benefit on the Quebec drug plans
Categories: Abilify | Schizophrenia
-
MONTREAL, QC, and TORONTO, ON - November 12, 2009
Health Canada Approves New Treatment for Adults With Type 2 Diabetes
ONGLYZA™ (saxagliptin) approval coincides with new research that shows 91 per cent of Canadians with diabetes are drifting in the management of their disease
-
MONTREAL, QUEBEC — October 6, 2009
Latest Treatment for Schizophrenia Offers Needed Additional Option to Fight Difficult-To-Treat Disease
ABILIFY™ now available in Canada with several benefits: efficacy, good safety, tolerability and neutral impact on weight, cholesterol and blood sugar levels
Categories: Abilify | Schizophrenia
Community
Events & Programs
BMS Canada is committed to community involvement. Find out more.
Careers
Looking for a Great Career?
Bristol-Myers Squibb Canada can offer you the challenge and support you are looking for in a friendly, motivating and exciting atmosphere. Find out more.